Nexgel Inc Net Income
| NXGL Stock | USD 1.30 0.01 0.76% |
As of the 18th of February 2026, Nexgel secures the Mean Deviation of 4.09, standard deviation of 5.99, and Risk Adjusted Performance of (0.08). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nexgel Inc, as well as the relationship between them. Please verify Nexgel Inc risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Nexgel Inc is priced some-what accurately, providing market reflects its recent price of 1.3 per share. Given that Nexgel Inc is a hitting penny stock territory we strongly suggest to closely look at its jensen alpha.
Nexgel Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.1006 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -3 M | -3.1 M | |
| Net Loss | -4.3 M | -4.5 M | |
| Net Loss | -3.1 M | -3.3 M | |
| Net Loss | (0.58) | (0.61) | |
| Net Income Per E B T | 1.09 | 1.07 |
Nexgel | Net Income | Build AI portfolio with Nexgel Stock |
Historical Net Income data for Nexgel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Nexgel Inc represents a compelling investment opportunity.
Latest Nexgel's Net Income Growth Pattern
Below is the plot of the Net Income of Nexgel Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Nexgel Inc financial statement analysis. It represents the amount of money remaining after all of Nexgel Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Nexgel's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexgel's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (3.28 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Nexgel Net Income Regression Statistics
| Arithmetic Mean | (2,412,203) | |
| Coefficient Of Variation | (42.25) | |
| Mean Deviation | 832,262 | |
| Median | (1,888,000) | |
| Standard Deviation | 1,019,270 | |
| Sample Variance | 1T | |
| Range | 3.8M | |
| R-Value | (0.68) | |
| Mean Square Error | 592.1B | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (137,739) | |
| Total Sum of Squares | 16.6T |
Nexgel Net Income History
Other Fundumenentals of Nexgel Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Nexgel Net Income component correlations
Nexgel Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Nexgel is extremely important. It helps to project a fair market value of Nexgel Stock properly, considering its historical fundamentals such as Net Income. Since Nexgel's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexgel's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexgel's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.
Nexgel 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nexgel's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nexgel.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Nexgel on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Nexgel Inc or generate 0.0% return on investment in Nexgel over 90 days. Nexgel is related to or competes with Retractable Technologies, Harvard Bioscience, Femasys, CytoMed Therapeutics, Nexalin Technology, Enlivex Therapeutics, and Milestone Scientific. NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels More
Nexgel Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nexgel's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nexgel Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 35.89 | |||
| Value At Risk | (9.24) | |||
| Potential Upside | 12.42 |
Nexgel Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexgel's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nexgel's standard deviation. In reality, there are many statistical measures that can use Nexgel historical prices to predict the future Nexgel's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.30) |
Nexgel February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 4.09 | |||
| Coefficient Of Variation | (884.45) | |||
| Standard Deviation | 5.99 | |||
| Variance | 35.85 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 35.89 | |||
| Value At Risk | (9.24) | |||
| Potential Upside | 12.42 | |||
| Skewness | 1.25 | |||
| Kurtosis | 3.54 |
Nexgel Inc Backtested Returns
Nexgel Inc has Sharpe Ratio of -0.0331, which conveys that the firm had a -0.0331 % return per unit of risk over the last 3 months. Nexgel exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nexgel's Mean Deviation of 4.09, standard deviation of 5.99, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.32, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexgel will likely underperform. At this point, Nexgel Inc has a negative expected return of -0.2%. Please make sure to verify Nexgel's potential upside and rate of daily change , to decide if Nexgel Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.12 |
Insignificant predictability
Nexgel Inc has insignificant predictability. Overlapping area represents the amount of predictability between Nexgel time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nexgel Inc price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Nexgel price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Nexgel Inc reported net income of (3.28 Million). This is 100.96% lower than that of the Health Care Equipment & Supplies sector and 103.29% lower than that of the Health Care industry. The net income for all United States stocks is 100.57% higher than that of the company.
Nexgel Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nexgel's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nexgel could also be used in its relative valuation, which is a method of valuing Nexgel by comparing valuation metrics of similar companies.Nexgel is currently under evaluation in net income category among its peers.
Nexgel Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nexgel from analyzing Nexgel's financial statements. These drivers represent accounts that assess Nexgel's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nexgel's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 14.5M | 7.0M | 12.1M | 29.0M | 33.4M | 19.6M | |
| Enterprise Value | 5.5M | 8.0M | 12.2M | 30.1M | 34.6M | 19.0M |
Nexgel Institutional Holders
Institutional Holdings refers to the ownership stake in Nexgel that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Nexgel's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nexgel's value.| Shares | Advisor Group Holdings, Inc. | 2025-06-30 | 305 | Bank Of America Corp | 2025-06-30 | 56.0 | Goss Wealth Management Llc | 2025-06-30 | 15.0 | Sbi Securities Co Ltd | 2025-06-30 | 7.0 | Ubs Group Ag | 2025-06-30 | 2.0 | Tower Research Capital Llc | 2025-03-31 | 0.0 | Jpmorgan Chase & Co | 2025-06-30 | 0.0 | Flaharty Asset Management, Llc | 2025-06-30 | 0.0 | Virtu Financial Llc | 2025-03-31 | 0.0 | Evernest Financial Advisors Llc | 2025-06-30 | 281 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 121.6 K |
Nexgel Fundamentals
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.25) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | 12.84 M | ||||
| Shares Outstanding | 8.14 M | ||||
| Shares Owned By Insiders | 15.39 % | ||||
| Shares Owned By Institutions | 6.43 % | ||||
| Number Of Shares Shorted | 1.17 K | ||||
| Price To Book | 2.04 X | ||||
| Price To Sales | 0.91 X | ||||
| Revenue | 8.69 M | ||||
| Gross Profit | 4.64 M | ||||
| EBITDA | (2.9 M) | ||||
| Net Income | (3.28 M) | ||||
| Cash And Equivalents | 9.79 M | ||||
| Cash Per Share | 1.76 X | ||||
| Total Debt | 2.83 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 4.33 X | ||||
| Book Value Per Share | 0.64 X | ||||
| Cash Flow From Operations | (3.87 M) | ||||
| Short Ratio | 0.49 X | ||||
| Earnings Per Share | (0.40) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 0.57 | ||||
| Market Capitalization | 15.55 M | ||||
| Total Asset | 10.98 M | ||||
| Retained Earnings | (18 M) | ||||
| Working Capital | 2.64 M | ||||
| Net Asset | 10.98 M |
About Nexgel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nexgel Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexgel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexgel Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.